NEW Enterprise Associates 13 L.P., 10% Owner at Omthera Pharmaceuticals, Inc. (OMTH), bought 5,833,409 shares at $8.00 ($10.1M) on 2013-04-16, disclosed to the SEC on 2013-04-17.
Open-market purchase of $10.1M OMTH by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,418,940 | $0 | 0.0% |
| 2 | $0.01 | 156,250 | $2K | 0.0% |
| 3 | $8.00 | 625,000 | $5.0M | 49.7% |
| 4 | $8.00 | 633,219 | $5.1M | 50.3% |
| Total | $1.73 avg | 5,833,409 | $10.1M | 100% |
| Filing → |
| TSRO | BUY | 2018-03-06 | $6.7M | — | Filing → |
| RARX | BUY | 2016-10-31 | $4.4M | — | Filing → |
| RARX | SELL | 2016-10-31 | $6K | — | Filing → |